Skip to content

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

A Multicenter, Retrospective Analysis to Evaluate Radiographic Outcomes and Safety Profiles Along Prospective Follow-Up Periods for Patients Implanted With 2 Levels of Prodisc® C Vivo Devices.

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07370493
Enrollment
200
Registered
2026-01-27
Start date
2025-11-01
Completion date
2030-12-01
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spine Degenerative Disc Disease, Cervical Spine Degenerative Disease, Degenerative Disc Disease, Symptomatic Cervical Disc Disease

Keywords

Degenerative disc disease, cervical spine degenerative disc disease, Cervical Total Disc Arthroplasty, Symptomatic Cervical Disc Disease

Brief summary

The objective of the study is to evaluate the safety and post-operative performance profile of the prodisc® C Vivo after implantation in comparison to the relevant clinical literature.

Detailed description

The primary objective of the study is to evaluate (estimate) the post-operative performance of prodisc® C Vivo overall, after implantation. Post-operative device performance will be estimated using Patient Reported Outcomes (PROs) and radiographic data derived from the patient's surgical charts and medical history. The secondary objectives of this study are to assess: * patients with no secondary surgical interventions (SSIs), i.e. revision, removal, re-operation, supplemental fixation at the index level(s) * the rates of ADEs inclusive of intraoperative and post-operative complications * Patient Reported Outcomes (PROs) * Outcome self-assessment of Health Survey (SF 12 or 36 as available)

Interventions

DEVICEProdisc C Vivo

The prodisc® C Vivo device is a non-keeled cervical disc replacement prosthesis. The device is modular intervertebral disc prostheses designed to replace a diseased and/or a degenerated disc of the cervical spine in SCDD patients, thereby restoring disc height, biomechanical stability and allowing the potential for motion at the affected vertebral segment.

Sponsors

Centinel Spine
Lead SponsorINDUSTRY
Avania
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* In order for a patient's data to be included in this study, he/she has to meet the indications and not possess any of the specific or general contraindications listed in the Instructions For Use (IFU). * They must provide written informed consent with appropriate documentation noted in source documentation (prospective cohort only).

Exclusion criteria

-There are no additional

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the Occurrence of Secondary Surgical Interventions in Patients Treated with prodisc® C Vivo at 2 Levels10 year post-operative screening of prodisc C Vivo patients implanted from JAN 2010 to presentThe primary objective of the study is to evaluate the post-operative performance of the prodisc® C Vivo after implantation by the occurrence of secondary surgical interventions in patients treated with prodisc® C Vivo at 2 levels. The State of the Art (SOTA) will be used as the comparison data collected in this study.

Secondary

MeasureTime frameDescription
Assessment to demonstrate the continuous clinical and radiographic status of the prodisc C Vivo implants allowing characterization of performance of the device by nominal variables (percentages) based on ADEs, SSIs, PROs, and SF 12 data collection10 Year Post-operative 10 year post-operative screening of prodisc C Vivo patients implanted from JAN 2010 to presentNominal variables will be presented as count (percent). For numerical variables, the results will be presented as minimum, 25th percentile, mean, standard deviation, median, 75th percentile and maximum. Frequency tables for system organ class and preferred terms will be compiled based on participants experiencing an ADE (Adverse Device Event), and on the number of ADEs (from initial surgery to present, including intraoperative and post-operative complications). These percentage variables will include multiple data collection factors, such as the number and proportions of patients with no secondary surgical interventions (SSIs) (revision, removal, re-operation, supplemental fixation) at the index level(s) from initial surgery to present, Patient Reported Outcome (PRO) assessments, and self-assessment of Health Surveys (SF 12).

Countries

Germany

Contacts

STUDY_DIRECTORJames Kuras, MS

Centinel Spine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026